Search clinical trials for: atenolol (beta blocker) and hydrochlorothiazide (diuretic)

Total 1411 results

University of Sao Paulo

Unknown

Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment

Blood Pressure

Brazil
Novartis

Completed

VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

Hypertension

Switzerland, Germany
University of Florida
Abbott

Completed

INVEST: INternational VErapamil SR Trandolapril STudy

Coronary Artery Disease | Hypertension

United States
Novartis

Completed

Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

Hypertension

Germany, Switzerland
Daiichi Sankyo, Inc.

Completed

Vascular Improvement With Olmesartan Medoxomil Study (VIOS)

Hypertension

United States
University of New Mexico
University of Pittsburgh; Dialysis Clinic, Inc.

Terminated

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Hypertension | Proteinuria | Type II Diabetes

United States
The George Institute
Byrraju Foundation; The Future Forum, UK

Completed

Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS) (RAPCAPS)

Myocardial Infarction | Diabetes Mellitus | Angina Pectoris | Cerebrovascular Accidents

India
Sankyo Pharma Gmbh

Completed

Olmesartan Medoxomil in Atherosclerosis

Essential Hypertension | Atherosclerotic Cardiovascular Disease

Germany
University of Cambridge
King's College London; Imperial College London; Barts & The London NHS Trust; University... and other collaborators

Unknown

Comparison of Single and Combination Diuretics in Low-Renin Hypertension (PATHWAY3)

Hypertension

United Kingdom
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Study of Atenolol Influence on Blood Pressure During Resistance Exercise

Exercise | Blood Pressure

Brazil
Curtin University

Active, not recruiting

Long-term Use of CCB and Breast Cancer Risk

Breast Cancer | Hypertension,Essential

Australia
Novartis

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Hypertension

United States
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI); National Center for Research...

Completed

Genetic Determinants of Response to Beta Blockade

Healthy

United States
Shanghai Jiao Tong University School of Medicine

Recruiting

The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.

Hypertension

China
Yonsei University

Completed

Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)

Small Abdominal Aortic Aneurysm

Korea, Republic of
Medical University of Vienna

Unknown

Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve

Optic; Neuritis, With Demyelination

Austria
University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Diuretics, Hypertension, and Arrhythmias Clinical Trial

Heart Diseases | Cardiovascular Diseases | Hypertension | Heart Arrest | Death, Sudden, Cardiac
Hospital de Clinicas de Porto Alegre
Instituto de Cardiologia do Rio Grande do Sul

Unknown

Efficacy of Chlorthalidone and Hydrochlorothiazide Combined With Amiloride on Blood Pressure in Primary Hypertension.

Hypertension

Brazil
Forest Laboratories

Completed

Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Hypertension

United States
Galenika AD Beograd
Medicinsko društvo za racionalnu terapiju Republike Srbije (MEDRAT)

Completed

Treatment of Resistant Hypertension: Cohort Study (TRYCORT)

Resistant Hypertension

Serbia
Daiichi Sankyo, Inc.

Completed

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Essential Hypertension

Italy, Poland, Ukraine, Germany, Spain, Bulgaria, Romania, Denmark, Belgium, Netherlands, Russian Federation, Hungary, Slovakia, Czechia, Latvia
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

Healthy
Nova Scotia Health Authority
Nova Scotia Health Research Foundation

Completed

Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF (SMAC AF)

Atrial Fibrillation

Canada
GlaxoSmithKline

Completed

Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions

Hypertension

South Africa
Guangdong Provincial People's Hospital

Completed

A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein (ANTI-UPRO)

Chronic Kidney Diseases

China
Novartis

Completed

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

Hypertension

India
Sanofi

Completed

Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension (COSIMA2)

Hypertension

India, Malaysia, Philippines, Singapore, Taiwan, Tunisia, Egypt, Korea, Republic of, Hong Kong, Indonesia, Morocco, Pakistan, Thailand, Vietnam
Takeda

Completed

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

Hypertension | Obesity

Germany
Novartis Pharmaceuticals

Terminated

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People (APOLLO)

Cardiovascular Events

Colombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
Institut de Recherches Cliniques de Montreal
Ottawa Hospital Research Institute

Completed

Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

Hypertension

Canada
University Hospital, Strasbourg, France

Suspended

Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

Hypertension | End Stage Renal Disease | Proteinuria

France
Fundación Centro Nacional de Investigaciones Cardiovasculares...

Recruiting

TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Myocardial Infarction

Spain, Italy
Alexandria University

Completed

Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure (GBDAL-HF)

Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV

Egypt
Shanghai Jiao Tong University School of Medicine

Recruiting

Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

Hypertension

China
Novartis

Completed

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

Hypertension

Switzerland, Germany
Boehringer Ingelheim

Completed

Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension

Hypertension
National Taiwan University Hospital

Unknown

A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome (MFS)

Marfan Syndrome

Taiwan
University of Florida

Completed

Pharmacogenomic Evaluation of Antihypertensive Responses

Hypertension

United States
Seoul National University Hospital

Completed

Effect of SLCO2B1 Genotype and Apple Juice on Pharmacokinetics of Atenolol After Oral Administration in Healthy Male Korean

Healthy

Korea, Republic of
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Trial of Antihypertensive Intervention Management

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

Hypertension

Switzerland
Boehringer Ingelheim

Completed

Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

Hypertension
Erasmus Medical Center

Completed

DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease (DD)

Chronic Kidney Disease

Netherlands
Daiichi Sankyo, Inc.

Completed

Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

Essential Hypertension

France, Poland, Ukraine, Belgium, Germany, Spain, Bulgaria, Romania, Denmark, Russian Federation, Netherlands, Austria, Slovakia, Czechia
Novartis

Completed

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus (ASTRIDE)

Hypertension | Diabetes Mellitus

United States
VA Office of Research and Development

Recruiting

Diuretics and Volume Overload in Early CKD (DOCK)

Hypertension | Chronic Kidney Disease

United States
Sanofi
Bristol-Myers Squibb

Completed

AMISH : Aprovel for Management of Isolated Systolic Hypertension

Hypertension

Korea, Republic of, Mexico, Taiwan, Thailand, Philippines, Chile, China, Indonesia
Novartis

Completed

Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.

Hypertension

Switzerland
Insel Gruppe AG, University Hospital Bern

Completed

Hydrochlorothiazide for Kidney Stone Recurrence Prevention (NOSTONE)

Nephrolithiasis

Switzerland

Search clinical trials for: atenolol (beta blocker) and hydrochlorothiazide (diuretic)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations